Zentalis Pharmaceuticals (ZNTL) Revenue (2024)
Zentalis Pharmaceuticals' (ZNTL) quarterly Revenue came in at $26.9 million in Q4 2024, down 33.76% quarter-over-quarter from $40.6 million in Q1 2024.
Zentalis Pharmaceuticals (ZNTL) Revenue (2024) Analysis & Trends
Zentalis Pharmaceuticals' Revenue history runs 1 years deep, the most recent figure standing at $26.9 million for Q4 2024.
- On a quarterly basis, Revenue changed N/A year-over-year to $26.9 million in Q4 2024; TTM through Sep 2025 was $26.9 million, a 33.76% decrease from a year earlier, with the FY2024 full-year figure at $67.4 million, changed N/A from the prior year.
- Revenue declined to $26.9 million in Q4 2024 per ZNTL's latest filing, from $40.6 million in the prior quarter.
- Across five years, Revenue topped out at $40.6 million in Q1 2024 and bottomed at $26.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 26.87 Mn |
| Mar 31, 2024 | 40.56 Mn |